Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR

We reported a relevant activity of the combination between sorafenib and octreotide long-acting release (LAR) in advanced hepatocellular carcinoma (HCC) patients. In this work, we have studied if oxidative stress in both serum and peripheral blood mononuclear cells (PBMC) and pERK activation status...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Caraglia, M, Giuberti, G, Marra, M, Addeo, R, Montella, L, Murolo, M, Sperlongano, P, Vincenzi, B, Naviglio, S, Prete, S Del, Abbruzzese, A, Stiuso, P
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2011
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3122065/
https://ncbi.nlm.nih.gov/pubmed/21525937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2011.34
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares